Zydus Wellness introduces a refreshed corporate brand identity, signaling a commitment to science-backed, consumer-centric ...

After a record FY25, the drugmaker sees new growth engines in biologics, vaccines, and devices powering expansion in FY26.

The identity refresh positions Zydus Wellness as an organization rooted in science, driven by compassion, and inspired by the ...

Zydus Wellness unveils new brand identity, reports strong financial growth, and focuses on science-backed innovation and ...

Zydus Lifesciences Q4 stuns with margin guidance, but brokerages trim targets — stock ends at Rs 890. Should you follow ...

ICICI Securities recommended hold rating on Zydus Lifesciences with a target price of Rs 910 in its research report dated May ...

The Subject Expert Committee (SEC) on Haematology has recommended for grant of permission to conduct a Phase-III clinical ...

Margin expansion will be a key focus for the company, with a long-term goal of reaching 17-18%, supported by operating ...

Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 970 in its research report ...

Zydus Lifesciences is on analysts' radar. The stock rose nearly 2% on Wednesday after reporting mixed fourth-quarter results.

Morgan Stanley believes India's fundamentals remain strong, supported by macro stability, improving terms of trade, declining ...

Zydus Wellness unveils a new corporate brand identity to reinforces its science-led purpose: Our Bureau, Bengaluru Wednesday, May 21, 2025, 15:40 Hrs [IST] Zydus Wellness has unve ...